175 related articles for article (PubMed ID: 17728468)
1. Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility.
Zhang SX; Parisian F; Yau Y; Fuller JD; Poutanen SM; Richardson SE
J Clin Microbiol; 2007 Nov; 45(11):3762-3. PubMed ID: 17728468
[TBL] [Abstract][Full Text] [Related]
2. Cephalothin susceptibility testing as class representative for oral cephalosporins: is it time to move on?
Nguyen HM; Graber CJ
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):483-5. PubMed ID: 23680238
[TBL] [Abstract][Full Text] [Related]
3. Summary of laboratory studies on the antibacterial activity of cefaclor.
Preston DA
Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
Greenberg RN; Bollinger M
Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
[TBL] [Abstract][Full Text] [Related]
5. Cephalothin is not a reliable surrogate marker for oral cephalosporins in susceptibility testing of Enterobacteriaceae causing urinary tract infection.
López IA; Montes JC; Álvarez MJ; Mazarrasa CF; Martínez-Martínez L
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):412-416. PubMed ID: 27640080
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cephalothin and cephalexin on various bacterial species isolated from biological material in the Regional Hygienic Station Bratislava].
Simkovicová M; Hausmannová Z; Sobotová Z
Cas Lek Cesk; 1976 May; 115(20-21):612-6. PubMed ID: 776399
[No Abstract] [Full Text] [Related]
7. Cephalexin susceptibility breakpoint for veterinary isolates: Clinical Laboratory Standards Institute revision.
Papich MG; Lindeman C
J Vet Diagn Invest; 2018 Jan; 30(1):113-120. PubMed ID: 29145786
[TBL] [Abstract][Full Text] [Related]
8. Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
Leverstein-van Hall MA; Waar K; Muilwijk J; Cohen Stuart J;
J Antimicrob Chemother; 2013 Nov; 68(11):2636-40. PubMed ID: 23766488
[TBL] [Abstract][Full Text] [Related]
9. Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria.
Greenwood D
Chemotherapy; 1977; 23(1):11-8. PubMed ID: 318970
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
[TBL] [Abstract][Full Text] [Related]
11. Cefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.
Turnidge JD;
Clin Infect Dis; 2011 Apr; 52(7):917-24. PubMed ID: 21427400
[TBL] [Abstract][Full Text] [Related]
12. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
Yeh LL; Chi CL
Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
[TBL] [Abstract][Full Text] [Related]
13. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
[TBL] [Abstract][Full Text] [Related]
14. [The implementation of the broth microdilution method to determine bacterial susceptibility to antimicrobial agents].
Rocksin A; Gerlach GF; Schwarz S
Berl Munch Tierarztl Wochenschr; 2007; 120(1-2):42-9. PubMed ID: 17290942
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.
Greenwood D
J Antibiot (Tokyo); 1978 Jul; 31(7):697-702. PubMed ID: 357363
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
Preston DA; Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
[TBL] [Abstract][Full Text] [Related]
19. Statistical study of intrinsic resistance in Escherichia coli.
Roy C; Segura C; Teruel D; Teixell M; Reig R; Hermida M
Chemioterapia; 1987 Jun; 6(2 Suppl):197-8. PubMed ID: 3334557
[No Abstract] [Full Text] [Related]
20. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Larsson P; Lincoln K; Lind L; Sandberg T
Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
